Surface proteomics reveals arginine metabolism as a vulnerability in high grade serous ovarian cancer
Govindarajan, M.; Waas, M.; Mejia-Guerrero, S.; Lin, B.; Ling, T.; Li, X.; Ignatchenko, V.; Tikhonova, A.; Jones, C.; Ailles, L.; Kislinger, T.
Show abstract
BackgroundThe significant lethality of high-grade serous ovarian cancer (HGSC) is driven by the lack of long-term efficacy of current treatments, underscoring the need for developing additional therapeutics. Cell surface proteins represent attractive therapeutic targets yet remain underexplored in high-grade serous ovarian cancer. Here, we employed cell surface N-glycoproteomics to elucidate the cell surface proteomes of HGSC cells alongside normal epithelial and cancer-associated stromal cells, uncovering new opportunities for therapeutic intervention. ResultsIntegration of cell surface N-glycoproteomics and functional screening revealed multiple minimally characterized, HGSC-enriched surface proteins that are critical for HGSC proliferation - most notably, SLC7A1. Multi-omic and functional characterization indicated that SLC7A1 is necessary for HGSC migration, protein synthesis and mitochondrial functions likely linked to its role as an arginine transporter. Finally, we demonstrate that elevated surface expression of SLC7A1 in HGSC reflects dysregulated arginine metabolism, pointing to a putative therapeutic vulnerability. ConclusionsOur work identifies SLC7A1 and arginine metabolism as a previously unrecognized molecular vulnerability in HGSC and provides a framework to guide future therapeutic development.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- HIRA loss transforms FH-deficient cells 95%
- Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug resistant gliomas 94%
- The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage. 94%
Similar papers in this journal
- A Multiomic Analysis Reveals How Breast Cancers Disseminated to the Bone Marrow Acquire Aggressive Phenotypes through Tumor-Stroma Tunnels 95%
- Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma 94%
- Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer 93%
Similar papers in this journal
- Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition 95%
- High-density, targeted monitoring of tyrosine phosphorylation reveals activated signaling networks in human tumors 95%
- NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy 94%